Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$233M |
| 2 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$211M |
| 3 |
Amazon
AMZN
|
+$164M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$135M |
| 5 |
Apple
AAPL
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$302M |
| 2 |
CTB
Cooper Tire & Rubber Co.
CTB
|
+$212M |
| 3 |
Ford
F
|
+$181M |
| 4 |
Booking.com
BKNG
|
+$170M |
| 5 |
JPMorgan Chase
JPM
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.39% |
| 2 | Technology | 15.98% |
| 3 | Industrials | 12.96% |
| 4 | Consumer Discretionary | 11.68% |
| 5 | Healthcare | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFI
3251
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $307K | ﹤0.01% |
+102,711
| New | +$325K |
|
3252
Great Elm Group
GEG
$67.7M
| $306K | ﹤0.01% |
136,435
-500
| -0.4% | -$1.27K |
|
3253
XP
XP
$8.75B
| $306K | ﹤0.01% |
7,019
-1,388
| -17% | -$57.4K |
|
|
AEY
3254
DELISTED
ADDvantage Technologies Group
AEY
| $305K | ﹤0.01% |
11,567
-657
| -5% | -$15.4K |
|
3255
Caledonia Mining Corp
CMCL
$361M
| $301K | ﹤0.01% |
24,891
-6,587
| -21% | -$92.6K |
|
|
OPNT
3256
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $301K | ﹤0.01% |
21,762
-69
| -0.3% | -$853 |
|
|
PFHD
3257
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $301K | ﹤0.01% |
+16,696
| New | +$298K |
|
|
AIM
3258
AIM ImmunoTech
AIM
$6.66M
| $299K | ﹤0.01% |
+1,393
| New | +$298K |
|
3259
Quest Resource Holding
QRHC
$28.4M
| $297K | ﹤0.01% |
46,775
+32,467
| +227% | +$150K |
|
3260
Puma Biotechnology
PBYI
$399M
| $296K | ﹤0.01% |
+32,281
| New | +$327K |
|
|
NARI
3261
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $295K | ﹤0.01% |
3,158
| – | – |
|
|
CIH
3262
DELISTED
China Index Holdings Limited American Depository Shares
CIH
| $295K | ﹤0.01% |
146,664
-11,615
| -7% | -$23.7K |
|
3263
Live Ventures
LIVE
$29.3M
| $294K | ﹤0.01% |
+4,776
| New | +$210K |
|
|
FFBW
3264
DELISTED
FFBW, Inc. Common Stock
FFBW
| $292K | ﹤0.01% |
25,642
+3,006
| +13% | +$33.8K |
|
|
VTNR
3265
DELISTED
Vertex Energy, Inc
VTNR
| $289K | ﹤0.01% |
21,850
-7,501
| -26% | -$31.1K |
|
3266
Ecopetrol
EC
$31.7B
| $287K | ﹤0.01% |
19,598
-30,497
| -61% | -$389K |
|
|
SGMA
3267
DELISTED
Sigmatron International
SGMA
| $286K | ﹤0.01% |
57,152
+2,098
| +4% | +$10.6K |
|
3268
J.W. Mays
MAYS
$78.7M
| $283K | ﹤0.01% |
9,194
-181
| -2% | -$4.97K |
|
3269
WIX.com
WIX
$2.48B
| $283K | ﹤0.01% |
974
-63
| -6% | -$17.7K |
|
|
SII
3270
Sprott
SII
$2.66B
| $282K | ﹤0.01% |
+7,181
| New | +$309K |
|
|
ZYNE
3271
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $282K | ﹤0.01% |
53,312
-1,554
| -3% | -$7.47K |
|
|
MSON
3272
DELISTED
Misonix Inc
MSON
| $282K | ﹤0.01% |
12,699
-35,162
| -73% | -$717K |
|
3273
Xenon Pharmaceuticals
XENE
$6.3B
| $279K | ﹤0.01% |
+15,010
| New | +$277K |
|
3274
Abeona Therapeutics
ABEO
$340M
| $277K | ﹤0.01% |
7,086
-1,597
| -18% | -$65.2K |
|
3275
Kamada
KMDA
$398M
| $277K | ﹤0.01% |
47,653
-1,726
| -3% | -$10.3K |
|
Similar funds
Dimensional Fund Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Dimensional Fund Advisors held 3,528 positions worth $316B, up 4.5% from $302B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dimensional Fund Advisors's Q2 2021 filing shows 120 new, 1,436 increased, 1,802 reduced and 67 closed positions. Its largest new stake was Organon & Co: 988,887 shares worth $29.9M. The largest sale was TCF Financial Corporation Common Stock, an estimated $302M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q2 2021 buy was Organon & Co: 988,887 shares worth $29.9M.
- Dimensional Fund Advisors added most to Huntington Bancshares in Q2 2021, an estimated $233M increase.
- Dimensional Fund Advisors's biggest Q2 2021 reduction was Ford, cutting an estimated $181M.
- Dimensional Fund Advisors fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $302M.
- Dimensional Fund Advisors's ten largest holdings make up 10% of its $316B portfolio in Q2 2021.
- Dimensional Fund Advisors opened 120 new positions and closed 67 in Q2 2021.
- Dimensional Fund Advisors's portfolio value rose 4.5% quarter-over-quarter to $316B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.